On September 30, 2009 Foley’s 2009 Life Sciences Conference, explored new legal and regulatory issues, creative financing strategies, and business opportunities for the life sciences community.
Special Keynote Speaker – Joshua Boger, Ph.D.
This year Foley welcomed Joshua Boger, Ph.D., founder and retired-CEO of Vertex Pharmaceuticals Incorporated and immediate-past-chairman of BIO’s Board of Directors. A true industry champion, Dr. Boger has a comprehensive understanding of the legal, scientific, and financial aspects of running a biotech company. During his opening keynote, Dr. Boger presented The Impact of Health Care Reform on Investment & Innovation in the Life Sciences Industry.
Lunch Keynote Presentation — Foley hosted Dr. Thomas Novak, Head of Discovery Technologies, Roche Palo Alto, who addressed the impact of cellular therapeutics on diagnostic medicine and personalized therapeutics within the pharmaceutical industry.
During a full day of in-depth panel discussions, life sciences CEOs, entrepreneurs, venture capitalists, managers, and in-house counsel addressed:
Innovative deal structures for today’s economy
Big pharma update and partnering opportunities
Key indicators of value & success: what investors are looking for
Life Sciences Opportunities in India & China
Please see below for presentation hand-outs and information on our speakers.
Co-Location Information
Foley’s Life Sciences Conference co-located with the Emerging Technologies Conference.